- Home
- FLR vs TFX Comparison
FLR vs TFX Comparison
Compare FLR & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLR
- TFX
- Stock Information
- Founded
- FLR 1912
- TFX 1943
- Country
- FLR United States
- TFX United States
- Employees
- FLR N/A
- TFX N/A
- Industry
- FLR Military/Government/Technical
- TFX Medical/Dental Instruments
- Sector
- FLR Industrials
- TFX Health Care
- Exchange
- FLR Nasdaq
- TFX Nasdaq
- Market Cap
- FLR 9.3B
- TFX 5.1B
- IPO Year
- FLR N/A
- TFX N/A
- Fundamental
- Price
- FLR $56.03
- TFX $113.93
- Analyst Decision
- FLR Buy
- TFX Hold
- Analyst Count
- FLR 7
- TFX 10
- Target Price
- FLR $54.43
- TFX $159.63
- AVG Volume (30 Days)
- FLR 2.7M
- TFX 522.5K
- Earning Date
- FLR 08-01-2025
- TFX 07-31-2025
- Dividend Yield
- FLR N/A
- TFX 1.18%
- EPS Growth
- FLR 563.49
- TFX N/A
- EPS
- FLR 10.64
- TFX 3.20
- Revenue
- FLR $16,563,000,000.00
- TFX $3,010,144,000.00
- Revenue This Year
- FLR $10.92
- TFX $3.50
- Revenue Next Year
- FLR $6.29
- TFX $5.33
- P/E Ratio
- FLR $5.23
- TFX $36.07
- Revenue Growth
- FLR 7.16
- TFX 0.29
- 52 Week Low
- FLR $29.20
- TFX $108.90
- 52 Week High
- FLR $60.10
- TFX $249.91
- Technical
- Relative Strength Index (RSI)
- FLR 68.01
- TFX 42.85
- Support Level
- FLR $52.27
- TFX $114.98
- Resistance Level
- FLR $57.50
- TFX $118.81
- Average True Range (ATR)
- FLR 1.38
- TFX 2.65
- MACD
- FLR -0.08
- TFX 0.27
- Stochastic Oscillator
- FLR 75.00
- TFX 49.65
About FLR Fluor Corporation
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services. The firm serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.